Shire tries to boost pipeline through SIMPLE expansion
This article was originally published in Scrip
Executive Summary
Shire has expanded its collaboration with Belgian biotech arGEN-X and invested €15m in the therapeutic antibody developer in a bid to boost its new drug pipeline.